Clinical diagnoses of sepsis that relate to bacterial infection were responsible for 650,000 admissions and 55,000 deaths in English hospitals last year. The vast majority of these patients are admitted to acute medicine units (AMUs) via Emergency Departments (EDs). AMUs and EDs are the areas where the biggest improvement in patient outcomes can be made, with better integrated, standardized and collaborative systems focused on early recognition, expedient intervention and senior review.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. McPherson D, Griffiths C, Williams M, et al. (2013). Sepsisassociated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ open; 3(8).
2. Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med.2015; 372(17): 1629–38.
3. Corfield AR1, Lees F2, Zealley I3, et al. Scottish Trauma Audit Group Sepsis Steering Group. Utility of a single early warning score in patients with sepsis in the emergency department. Emerg Med J. 2014; 31(6): 482–7.
4. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/331871/English_National_Point_Prevalence_Survey_on_Healthcare_associated_Infections_and_Antimicrobial_Use_2011.pdf.
5. Daniels, Nutbeam & Inada-Kim. Acute Care Toolkit 9: Sepsis. Royal College of Physicians, 2014.
6. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589–96.
7. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344–53.
8. Dellinger, R. Phillip, et al. “Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.” Intensive care medicine, 2004; 30(4): 536–555.
9. The Parliamentary and Health Service Ombudsman report. Time to act. Severe sepsis: rapid diagnosis and treatment saves lives.
10. Levy, Mitchell M, et al. “The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.” Intensive care medicine, 2010; 36(2): 222–231.
11. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38: 1–8.
12. Gao F, Melody T, Daniels D. F, et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Critical care, 2005; 9(6): R764.
13. Cronshaw H. L, Daniels R, Bleetman A, et al. Impact of the Surviving Sepsis Campaign on the recognition and management of severe sepsis in the emergency department: are we failing? Emergency Medicine Journal, 2011; 28(8): 670–675.
14. Müller B, Becker K. L, Schächinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Critical care medicine, 2000; 28(4): 977–983.
15. Phua J, Koay E. S, & Lee K. H. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock, 2008; 29(3): 328–333.
16. Viallon A, Guyomarc’h S, Marjollet O, et al. Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin. European Journal of Emergency Medicine, 2008; 15(1): 26–33.
17. Anand D, Das S, Bhargava S, et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: A prospective, observational, cohort study. J Crit Care. 2014 6. pii:S0883-9441(14)00346-3.
18. Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014; 34(4): 263–73. doi: 10.3343/alm.2014.34.4.263. Epub 2014 Jun 19.
19. Wacker et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. The Lancet Infectious Diseases, 2013; 13: 426–435.
20. Trzeciak S, Dellinger RP, Chansky ME, et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med.2007; 33: 970–7.
21. Nguyen H Bryant, Rivers Emanuel P, Knoblich, Bernhard P et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Critical Care Medicine, 2004; 32(8): 1637–1642.
22. Christ-Crain M, Morgenthaler N. G, Struck J, et al. Midregional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care, 2005; 9(6): R816–R824.
23. Suberviola B, Castellanos A, Astudillo L. G, et al. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia. Critical Care, 2011; 15: 1–190.